Convergency’s mission is to help clients achieve success in digital transformation. With three decades of experience designing and implementing large scale technical solutions, Convergency brings a unique perspective and skillset to digital transformation for companies in heavily-regulated industries.
Who We Are
Convergency is a consulting and advisory firm for life sciences, pharmaceuticals, biotech, financial and fintech. We have a track record of delivering “right-sized” solutions, at a fraction of the cost and time of traditional consulting firms. Our core competency includes design and implementation of Integrated Data Environments and Clinical Trial Management Decoupling, while developing more effective and efficient processes along the entire drug delivery value chain.
Our mission is laser-focused on helping our clients succeed, so that they can increase patient value and shareholder value. We partner with cutting-edge and industry leading technology providers, to ensure that our clients are at the forefront of new developments.
Convergency’s consultants have decades of experience designing and implementing integrated data environments and reducing drug delivery cycles by 20 to 35 percent. Convergency unlocks the value of data by bringing together process improvement practices (based on Lean Six Sigma practice), data analytics, AI, along with key infrastructure and cloud-based technology in Amazon AWS, Microsoft Azure, Reltio, Tableau, QlikSense and Talend.
We pride ourselves on being flexible and adaptable, based on client requirements and objectives. We strive to be under budget and on time for every single project. Convergency was founded by Brian Nigl, who provides a unique perspective and set of experiences to client challenges in this new era of digital transformation. Brian has over 30+ years experience in pharma, and other heavily-regulated industries, helping businesses transform and achieve competitive advantage.